IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,354 | +3350.5% | 13,566 | +2618.6% | 0.00% | – |
| Q1 2023 | $17,834 | -99.8% | 499 | -99.7% | 0.00% | -100.0% |
| Q4 2022 | $7,189,633 | +14.0% | 190,353 | +33.6% | 0.04% | +21.9% |
| Q3 2022 | $6,304,000 | +16.1% | 142,522 | -2.8% | 0.03% | +28.0% |
| Q2 2022 | $5,429,000 | +49254.5% | 146,656 | +77087.4% | 0.02% | – |
| Q3 2019 | $11,000 | -60.7% | 190 | -55.8% | 0.00% | – |
| Q2 2019 | $28,000 | +40.0% | 430 | +78.4% | 0.00% | – |
| Q1 2019 | $20,000 | -88.6% | 241 | -94.0% | 0.00% | -100.0% |
| Q1 2018 | $176,000 | -38.7% | 4,000 | -33.3% | 0.00% | -50.0% |
| Q4 2016 | $287,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |